Scientists have taken a "very positive step" towards creating a universal vaccine against cancer, say experts.
Reported in the journal Nature, the potential new therapy involves patients' immune systems attacking tumours as if they were viruses.
Pieces of cancer's genetic RNA code were placed into nanoparticles of fat and injected into three patients in the advanced stage of the disease. In response, the immune systems produced cells designed to specifically attack the disease.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The vaccine was also found to be effective in fighting "aggressively growing" tumours in mice, say the researchers, who were led by Professor Ugur Sahin from Johannes Gutenberg University in Germany.
"The vaccines are fast and inexpensive to produce and virtually any tumour antigen can be encoded by RNA," said Sahin.
"The approach introduced here may be regarded as a universally applicable novel vaccine class for cancer immunotherapy."
Dr Helen Rippon, the chief executive of Worldwide Cancer Research, described it as a "very positive step forwards towards the global goal of a 'universal cancer vaccine'".
She added: "We know the immune system has great potential to be manipulated and reactivated to fight cancer cells. These are exciting and novel results, showing the promise of an RNA nanoparticle vaccine to do just that."
The genetic code could be "programmed" for any cancer, says the Daily Telegraph. "All doctors would need is the genetic profile of the tumour to make a custom-made vaccine which, as well as fighting the disease, would prevent it ever returning."
While heralding the breakthrough, Dr Aine McCarthy, Cancer Research UK's senior science information officer, warned that larger clinical trials were needed to confirm that it "works and is safe. More research is also needed to determine if it can be used to treat other types of cancer, she said.
It is "still very early days", says ScienceAlert, but we have "another reason to feel hopeful about the future of cancer treatment – and that's always a good thing".
-
Political cartoons for January 31Cartoons Saturday's political cartoons include congressional spin, Obamacare subsidies, and more
-
Syria’s Kurds: abandoned by their US allyTalking Point Ahmed al-Sharaa’s lightning offensive against Syrian Kurdistan belies his promise to respect the country’s ethnic minorities
-
The ‘mad king’: has Trump finally lost it?Talking Point Rambling speeches, wind turbine obsession, and an ‘unhinged’ letter to Norway’s prime minister have caused concern whether the rest of his term is ‘sustainable’
-
Israel retrieves final hostage’s body from GazaSpeed Read The 24-year-old police officer was killed during the initial Hamas attack
-
China’s Xi targets top general in growing purgeSpeed Read Zhang Youxia is being investigated over ‘grave violations’ of the law
-
Panama and Canada are negotiating over a crucial copper mineIn the Spotlight Panama is set to make a final decision on the mine this summer
-
Why Greenland’s natural resources are nearly impossible to mineThe Explainer The country’s natural landscape makes the task extremely difficult
-
Iran cuts internet as protests escalateSpeed Reada Government buildings across the country have been set on fire
-
US nabs ‘shadow’ tanker claimed by RussiaSpeed Read The ship was one of two vessels seized by the US military
-
How Bulgaria’s government fell amid mass protestsThe Explainer The country’s prime minister resigned as part of the fallout
-
Femicide: Italy’s newest crimeThe Explainer Landmark law to criminalise murder of a woman as an ‘act of hatred’ or ‘subjugation’ but critics say Italy is still deeply patriarchal
